Express Pharma - Express Pharma

Board of directors recommends dividend of 0.25 paisa per share

If approved, this could be the first pharmaceutical therapy to treat patients with vitreomacular adhesion

The 20-member delegation will also attend Arogya 2012

To set up a scientist exchange programme between India and Denmark

To yield actionable insights and more effective personalised treatments

It is a new option for both first and second-line treatment

Taro will become a privately held company, will be wholly owned by affiliates of Sun Pharma

This was experienced by patients who take cholesterol-lowering drugs

Plant will support future growth in the region

Plant will support future growth in the region